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1. Introduction
Heart rate (HR) is a variable parameter that rapidly adjusts to changing hemodynamic de‐
mands (Fig. 1). HR is determined by several mechanisms. First, chronotropic regulation of
the heart occurs through spontaneous and periodic depolarization of sino-atrial (SA) pace‐
maker cells. The activity of the SA node is modulated by the autonomic nervous system, in‐
trinsic cardiac nervous system, baroreflexes, and respiration. Second, the sympathetic
nervous system (SNS) stimulates postganglionic sympathetic nerve fibers and triggers nore‐
pinephrine release in the SA node that results in an increase in HR. Third, the parasympa‐
thetic nervous system (PNS) also plays a significant role in regulation of HR.
Parasympathetic vagal nerve endings release acetylcholine, which binds to muscarinic choli‐
nergic receptors on pacemaker cells, causing opening of potassium channels, hyperpolariza‐
tion of the membrane, and, consequently, a decrease in HR. Fourth, humoral and
mechanical signals have an effect on HR and its variability. Mechanoreceptors in the atrium
respond to stretch (occurs during respiration) and change HR without neural input [1].
Changes in blood pressure (BP) impact HR via baroreceptor reflexes. In response to high BP,
stretch-sensitive receptors in the carotid sinus and aortic arch send action potentials via the
vagus and glossopharyngeal nerves to the solitary tract nucleus (NTS) of the brainstem. The
NTS affects the ventrolateral medulla is causing an inhibition of sympathetic drive and acti‐
vates the PNS by triggering the nucleus ambiguous. The result is a decrease in HR and BP.
In response to hypotension, the baroreceptor reflex works in the opposite direction, leading
to an increase in sympathetic drive and decrease in vagal tone, which raises HR and BP. Me‐
chanical signals also lead to respiratory sinus arrhythmia – increased in HR during inhala‐
tion and decreased HR during exhalation. This normal physiologic phenomenon involves an
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increase in intrathoracic volume during inspiration that results in an increase in HR by acti‐
vation of SNS and a decrease in parasympathetic tone. The integrated spectral power of
high frequency (HF, >0.15Hz) HR variability (HRV) is used as an index of the level of para‐
sympathetic activity. Low frequency (LF, 0.04–0.15Hz) power of HRV reflects both sympa‐
thetic and parasympathetic activity and the LF/HF ratio is an indicator of sympatho-vagal
balance [2]. Body temperature plays a relatively minor role in HRV. It has been shown that
hypothermia is associated with bradycardia (decrease in HR) and fever associates with ta‐
chycardia (increase in HR) in neonates [3]. However, the contribution of baseline HR to
HRV is relatively small. Very low and ultra low frequency ranges of HRV indicate altera‐
tions in body temperature.
Figure 1. A scheme that shows regulation of heart rate. Heart rate (blue color) is determined by there major com‐
ponents. First, cardiomyocyte regulation (red color) is driven by depolarization of pacemaker cells. Second, neuronal
regulation (black color) includes two components: sympathetic nervous system (SNS; brown color) and parasympa‐
thetic nervous system (PNS; green color). Third, stress factors (dark red color) are important for modulation of the
heart rate. Please, see text for details.
Genetic Disorders90
Increased HR has been shown as a predictor of cardiovascular mortality in healthy people,
myocardial infarction (MI) and heart failure patients [4]. The increased mortality observed
with an increased HR may be a consequence of the SNS/PSN imbalance that can be charac‐
terized by SNS predominance, vagal depression, or the combined impact of this dysregula‐
tion of cardiovascular function [5]. Elevated HR increases short-term cardiac output and
myocardial oxygen consumption, while simultaneously reducing time of diastole and myo‐
cardial blood supply that leads to development of myocardial ischemia and arrhythmias [6].
Analysis of HRV data has provided clinically useful information about the status of the car‐
diovascular system. For example, Fourier spectral analysis of HR data has shown that fre‐
quency profiles of HRV are altered in hypovolaemia, heart failure, hypertension, coronary
artery disease, angina and MI [7-12]. Acute brain injury has been linked to decreased HRV
as well [13]. Chronic pathological conditions like diabetes, hyperglycemia, hyperlipidemia,
obesity, and kidney failure are shown to lead to autonomic dysregulation of HR and usually
associates with low HRV values [14]. Inoue and colleagues [15] showed that for every 10
beats per minute (beats/min) increase in HR, the odds ratio of an increase in white blood
cells is approximately 1.3 in both men and women. These findings indicate that resting HR
is clinically important for chronic inflammation and future cardiovascular events. Numer‐
ous studies have demonstrated a strong association between decreased HRV and sepsis [16,
17]. HRV is also altered in psychiatric disorders like depression [18]. In some of these condi‐
tions abnormal HRV appears to be linked to an over-activation of the SNS and hypothala‐
mic-pituitary-adrenal axis [19].
Given the complexity of HR regulation it is difficult to understand pathological mechanisms
that alter HR. As shown in other complex traits, genetic factors play an important role in HR
and HRV in humans. For example, Singh et al. [20] reported that heritability might explain a
substantial proportion of the variance in HR and HRV based on twin study. Here, we sum‐
marize the current facts on the genetic mechanisms of HR regulation and discuss the poten‐
tial impact of HR genes on progression of cardiovascular diseases.
2. Body
2.1. Genetics of HR trait in humans
The majority of clinical studies have focused on electrophysiological abnormalities in the
heart (e.g., long QT syndrome) because of their importance in sudden death [21]. However,
we still have an incomplete view on the genetic contribution to resting HR variation. For the
past decade genetic studies in humans revealed a number of genomic loci that control HR
variation (Table 1). A first linkage analysis for resting HR was performed in 962 Caucasians
and 1,124 African-Americans in the Hypertension Genetic Epidemiology Network (Hyper‐
GEN) cohort [22]. A major locus was detected on chromosome 4 (195.06cM) with logarithm
of odds ratio (LOD) score of 3.18 for both racial groups. This study also indicated that chro‐
mosome 10 may harbor a locus that contributes to HR [22]. Martin et al [23] investigated a
population that contained 2,209 normotensive and hypertensive individuals. The authors re‐
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ported ~26% heritability and found a significant locus on human chromosome 4 (128Mb;
LOD=3.9). Ankyrin-B (ANK2) and myozenin 2 (MYOZ2) were proposed as candidate genes
for variation in resting HR. ANK2 promotes targeting of ion channels to the membranes in
cells. MYOZ2 may play a significant role in cardiac activity via excitation-contraction cou‐
pling. Thus, MYOZ2 may indirectly influence calcium signaling and pacemaker function in
the heart. In a larger study of 3,282 Caucasian and African-American populations (Family
Blood Pressure Program) two loci were found [24]. A significant locus on chromosome 10
(142.78cM; LOD=4.6) was linked to HR in the Caucasian group of HyperGEN. However, a
common region on chromosome 5p13-14 (LOD=1.9) influenced HR in both races [24]. Ge‐
nome-wide linkage for HR showed a peak on chromosome 18 (77cM; LOD = 2.03) in 73
Mongolian families [25]. Two genes SLC14A2 (solute carrier family 14 urea transporter) and
LIPG (endothelial lipase precursor) are likely candidates in the chromosome 18 locus. The
second peak (LOD=1.52) was identified on chromosome 5 (216cM). These findings further
support the importance of the genes on human chromosome 5 for HR regulation (Table 1).
The identified genomic region contains NSD1 (nuclear receptor SET domain-containing
gene 1) gene that enhances transactivation of the androgen receptor. This region also con‐
tains F12 (coagulation factor XII) gene and is associated with cardiac risks [25]. The analyses
of HR (measured as the RR interval) in 2,325 individuals from three isolated European pop‐
ulations revealed a significant locus on chromosome 12 [26]. In particular, two intronic sin‐
gle nucleotide polymorphisms (SNPs) (rs885389 and rs1725789) were located in a G-protein–
coupled receptor 133 (GPR133) gene on chromosome 12 that exceeded the threshold of ge‐
nome-wide significance (P=3.9x10-8 and 1.5x10-7, respectively). For rs885389, each risk allele
brings a decrease in 14ms in the length of the RR interval, and for rs1725789 – decrease in
16ms [26]. A significant quantitative trait locus (QTL) for HR (chromosome 9p21; LOD=4.8)
was reported in the Strong Heart Family Study [27]. The linkage analyses were performed
for HR, which was measured by electrocardiogram and echocardiograph Doppler recording
in this population. Six significant SNPs were identified (rs7875153, rs7848524, rs4446809,
rs10964759, rs1125488 and rs7853123) and the rs7875153 provided the strongest evidence for
association and is located within a hypothetical protein with an undefined function
(KIAA1797). However, KIAA1797 interacts with vinculin (VCL), which is involved in devel‐
opment of dilated cardiomypathy. Several genome-wide linkage studies assessed the in‐
volvement of the genetic factors in exercise HR response to training [28, 29]. In particular,
the HERITAGE Family Study identified several genetic loci in 99 white and 127 black fami‐
lies [28]. Interestingly, there were differences in genetic loci between two races for baseline
resting HR: for white families – chromosomes 4 and 11, for black – 2, 6, 7, 12, 14 and 15. For
training HR response the following loci were identified: for white families – chromosomes 1
and 21, while loci on chromosomes 3, 20 and 21 were found in black families [28]. A follow
up analysis of this cohort identified two SNPs that are located in the 5'-region of the cAMP-
responsive element-binding protein 1 (CREB1) gene on chromosome 2 [29]. Most recently,
the same group reported SNPs in nine genes (including CREB1) that explain heritability of
training HR in the related to HERITAGE Family Study [30]. The proposed candidate genes
might regulate cardiomyocyte and neuronal cell functions, as well as cardiac memory for‐
mation, fully accounting for the heritability of the submaximal HR training response.
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Chromosome Study Reference
2 HERITAGE Family Study An et al, 2006
Rankinen et al, 2010
Rankinen et al, 2012
4 Hypertension Genetic Epidemiology Network (HyperGEN)
Metabolic Risk Complications of Genes Obesity Project
HERITAGE Family Study
Wilk et al, 2002
Martin et al, 2004
An et al, 2006
5 Family Blood Pressure Program Laramie et al, 2006
6 HERITAGE Family Study
meta-analysis of 15 GWA studies
An et al, 2006
Eijgelsheim et al, 2010
7 HERITAGE Family Study
meta-analysis of 15 GWA studies
An et al, 2006
Eijgelsheim et al, 2010
9 Strong Heart Family Study in American Indians Melton et al, 2010
10 Hypertension Genetic Epidemiology Network (HyperGEN)
Family Blood Pressure Program
Wilk et al, 2002
Laramie et al, 2006
11 HERITAGE Family Study
meta-analysis of 15 GWA studies
An et al, 2006
Eijgelsheim et al, 2010
12 HERITAGE Family Study
3 isolated European populations
meta-analysis of 15 GWA studies
An et al, 2006
Marroni et al, 2009
Eijgelsheim et al, 2010
14 HERITAGE Family Study
meta-analysis of 15 GWA studies
An et al, 2006
Eijgelsheim et al, 2010
15 HERITAGE Family Study An et al, 2006
18 Mongolian Family Study Gombojav et al, 2008
Table 1. Heart rate controlling genetic loci in humans
Genome-wide association (GWA) studies became a powerful approach to identify common
variants associated with cardiovascular diseases. A recent meta-analysis of 15 GWA studies
for HR variation included 38,991 subjects of European ancestry [31]. Authors used an adjust‐
ed RR interval for association analyses in approximately 2.5 million genomic markers. Six
novel associations with resting HR were found: 6q22; 14q12; 12p12; 6q22; 7q22; and 11q12.
Locus 6q22 is near a gap junction protein, alpha 1 (GJA1) gene that encodes connexin-43
protein and is crucial in electrical coupling of the myocytes. Mutations in GJA1 cause an in‐
herited hypoplastic left heart syndrome. The second locus on 6q22 is located near SLC35F1
that encodes hospholamban. The 14q12 locus is near myosin heavy chain-6 protein (MYH6),
which is related to hypertrophic cardiomyopathy, atrial-septal defects and dilated cardio‐
myopathy. The locus on chromosome 12p12 includes several genes (SOX5, c12orf67, BCAT1,
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LRMP and CASC1) without any pathophysiological association with cardiac diseases. In the
7q22 locus a candidate gene, SLC12A9, encodes a cation-chloride co-transporter-interacting
protein was found. Finally, the 11q12 locus is near FADS1 (arachidonyl-CoA) gene, which
has been shown to release Ca2+ from the sarcoplasmic reticulum. Previously published asso‐
ciations were confirmed for GJA1, MYH6 and CD34. These variants explain approximately
0.7% of RR interval variance. Only 1.6% of resting HR variance can be explained by 20 poly‐
morphisms in this study [31]. The latter suggest a substantial polygenic nature of the resting
HR trait. Despite great progress in our understanding of the genetics of HR variation we
have a limited knowledge of the genetic causes.
2.2. Genetic studies of HR trait in rodents
Utilization of laboratory animals has been successful in uncovering genetic causes of cardio‐
vascular diseases. One of the major advantages of animal studies is that they have minimal
environmental and methodological effects as compared to human studies. Historically, ge‐
netic crosses between two inbred lines with a robust cardiovascular variation are widely
used to identify QTLs in rodents (Table 2). Studies in rats have been aimed at understanding
the genetics of BP variation by using spontaneously hypertensive rats (SHR), stroke-prone
spontaneously hypertensive rats (SHRSP) and Dahl rats (salt-sensitive hypertension). How‐
ever, several genetic crosses uncovered QTLs that control HR trait independently from BP
(Table 2). For example, HR variation after 12 days of salt-load was tested in the cross be‐
tween SHRSP and Wistar-Kyoto rats (WKY), and identified a significant locus (LOD=5.9) on
rat chromosome 3 [32]. In the center of the locus is SNC2α1 gene that encodes a brain iso‐
form of α1 polypeptide of the type 2 voltage-gated sodium channel. In a cross between SHR
and normotensive Brown-Norway (BN) rats a significant locus that controls elevated HR
was found on rat chromosome 8 (6.8cM; LOD= 8.7) [33]. This segment of rat chromosome 8
harbors over 200 genes. The more likely candidates for HR are subtypes of nicotinic acetyl‐
choline receptor α3 (CHRNΑ3), α5 (CHRNΑ5), and β (CHRNΒ4); hyperpolarization-activat‐
ed channel (HCN4); 5-hydroxytryptamine (serotonin) receptor 3A (HTR3A) and 3B
(HTR3B); and sodium channel (SCN2). Studies on congenic strains with varying segments of
chromosome 2 between SHR and WKY rats identified a new HR locus [34]. Another congen‐
ic strain of chromosome 10 from Dahl rat revealed increased HR and short QT interval loci
[35]. Authors found that overexpression of a candidate gene, rififylin (RFFL), increased car‐
diomyocyte beating in congenic rats. In addition to resting HR, one genetic study examined
a stress-related HR variation in WKY and SHR cross progeny with 23 recombinant inbred
rat strains (HXB-BXH) [36]. Specifically, genetic loci that are involved in HR responses to
stress (an airpuff startle test) are located on rat chromosomes 1, 2 and 10. BN allele on rat
chromosome 2 (D2Rat62-D2Rat247, LOD=2.9) enhanced the bradycardia in early response to
the stress. Two significant QTLs for tachycardia responses were identified on rat chromo‐
some 1 (D1Rat287-D1Rat292, LOD=3.1) and chromosome 10 (D10Rat26- D10Rat267,
LOD=2.4). Thus, seven loci were identified in hypertensive rat models that are specific to HR
variation with minimal effect from BP.
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Chromosome Study Reference
Rat
1 WKY x SHR cross and 23 HXB-BXH strains Jaworski et al, 2002
2 WKY x SHR cross and 23 HXB-BXH strains
Congenic SHR
Jaworski et al, 2002 Alemayehu
et al, 2002
3 SHRSP x WKY cross Kreutz et al, 1997
8 BN x SHR Silva et al, 2007
10 WKY x SHR cross and 23 HXB-BXH strains
Congenic Dahl
Jaworski et al, 2002
Gopalakrishnan et al, 2011
Mouse
1 BALB x CBA cross
C57BL/6 x DBA/2 cross
Sugiyama et al, 2002
Blizard et al, 2009
2 BALB x CBA cross Sugiyama et al, 2002
4 FVB/NJ x 129P2 sensitized mutants cross Scicluna et al, 2011
5 30 Inbred strains and 29 AXB-BXA strains
C57BL/6 x DBA/2 cross
Howden et al, 2008
Blizard et al, 2009
6 30 Inbred strains and 29 AXB-BXA strains Howden et al, 2008
7 C3HeB x SJL cross,
30 Inbred strains and 28 AXB-BXA strains
Smolock et al, 2012
15 BALB x CBA cross
C57BL/6 x DBA/2 cross
Sugiyama et al, 2002
Blizard et al, 2009
Table 2. Heart rate controlling genetic loci in rodents
Mouse  studies  identified  HR  genetic  loci  that  independent  of  BP  variation  (Table  2).
Three significant QTLs were identified on mouse chromosomes 1, 2, and 15 in the BALB/
CJxCBA/J backcross [37].  The HR quantitative trait  1  (Hrq1) locus was found on mouse
chromosome  2  (72cM;  LOD=4.0)  and  Hrq2  on  chromosome  15  (25cM;  LOD=3.1).  The
chromosome  2  locus  contains  a  cholinergic  receptor,  nicotinic,  polypeptide  alpha  1
(CHRNΑ1) gene. Two of the muscarinic receptors are also the Hrq1 locus, CHRM4 (chol‐
inergic  receptor,  muscarinic  4)  and CHRM5.  The authors  also  found the  Hrq3 locus  on
chromosome 1 that  significantly interacts  with the Hrq1 locus [37].  Electrocardiographic
evaluation  of  26  AXA/BXA  recombinant  mouse  inbred  strains  and  linkage  analyses  re‐
vealed  HR and HRV loci  [38].  The  most  significant  QTL for  HR was  found on  mouse
chromosome 6  (54Mb,  LOD=3.8).  This  locus  contains  several  candidate  genes  associated
with HR regulation, including corticotropin-releasing factor receptor 2 (CRHR2) and neu‐
ropeptide  Y  (NPY).  This  study also  uncovered  a  HF-HRV locus  that  was  identified  on
mouse chromosome 5 (54Mb, LOD=3.1). Candidate genes for HF-HRV included D5 dop‐
amine receptor (DRD5),  peroxisome proliferative-activated receptor-coactivator-1 (PCG1),
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and endothelial  nitric  oxide synthase (ENOS).  Two significant  QTLs were reported in a
cross  between  C57BL/6J  and  DBA/2J  strains  [39].  In  particular,  a  female-specific  locus
was  found  on  mouse  chromosome  1  (72cM,  LOD=7.9)  and  gender-uniform  locus  on
mouse chromosome 5  (54cM, LOD=8.5).  A repeaded HR measurements  showed a  locus
for  HR  on  chromosome  15  (2cM,  LOD=3.1).  Importantly,  two  significant  QTLs  for  HR
were  confirmed  in  BXD  recombinant  inbred  strains.  L-type  calcium  channel  (CAV1.1)
and regulator of G protein signaling (RGS2) are the two candidate genes within the HR
locus  [39].  A  linkage  analysis  for  HR  variation  in  a  sensitized  mouse  mutant
(SCN5A-1798insD/+) was studied in F2 progeny from the FVB/NJx129P2 cross [40]. Interval
mapping found a HR locus on chromosome 4 (136-151Mb, LOD=4.2). Finally, we report‐
ed a highly significant QTL for elevated HR on chromosome 7 (41 cM, LOD = 6.7) in the
C3HeB/FeJxSJL/J backcross [41]. We mapped this locus using a GWA analyses in the Hy‐
brid Mouse Diversity Panel (HMDP) that included 30 inbred and 28 AXB/BXA recombi‐
nant  inbred strains.  We detected seventeen significant  SNPs within a  0.9Mb interval  on
mouse  chromosome 7.  This  locus  contains  a  cluster  of  three  gamma-Aminobutyric  acid
(GABA) A receptor subunit genes: GABRβ3, GABRα5, and GABRγ3. These receptor sub‐
units are responsible for inhibitory effects of neurotransmitter GABAA  in the brain. Tak‐
en  together,  animal  studies  yielded a  similar  number  of  the  genetic  loci  as  reported in
humans for HR variation.
2.3. Challenges and future directions in the genetic studies on HR variation
Despite the progress in technology of the high throughput wide-genome screens in human
populations, the methodological challenges are attributed to variability of HR. In addition,
BP levels and/or responses to therapy may further limit our abilities to dissect the genetic
basis of HR variation in humans. For example, retrospective analyses of several anti-hyper‐
tensive trials revealed potential methodological differences [42]. Specifically, clinical, ambu‐
latory and home monitoring methods might introduce inter-individual variability that could
complicate genetic analyses. One approach is to increase the number of the assessments of
hemodynamics per individual. For example, repeated measurements have improved repro‐
ducibility between the measurements taken on the same day and between days in heart fail‐
ure patients [43]. Therefore, more uniform methods of evaluation of HR trait should be
considered in large genetic studies in humans. Animal experiments are proven as better-
controlled genetic models for complex traits. However, there are similar genetic loci identi‐
fied on the HR trait between human and animal studies (Tables 1-2). The latter suggests a
clear need for more genetic experiments in animal models. GWA and traditional genetic ap‐
proaches (genetic intercrossed and congenic lines) should improve mapping results. We re‐
cently combined two approaches and mapped a novel genetic locus on mouse chromosome
7 that contains three candidate genes [41]. Overview of the current candidate genes suggests
involvement of three major components in HR regulation: 1) cardiomyocyte cell function; 2)
neuronal cell functions; and, 3) stress-related pathways (Fig. 1). So far only a limited number
of HR candidates were validated in genetically targeted animal models. In particular, mice
heterozygous for ANK2 that phenocopy human sinus node dysfunction, displayed severe
bradycardia and HRV [44]. Several mouse mutants were made to target a class of hyperpo‐
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larization-activated cyclic nucleotidegated (HCN) cation channels [45]. It was concluded
that the HCN4, HCN1 and HCN2 subunits are important for generation of the pacemaker
current in the SA cells [45]. RGS2 knockout mice exhibited autonomic abnormalities in regu‐
lation of hemodynamic parameters [46]. Authors found that RGS2 knockout mice had an in‐
creased sympathetic tone and exhibited baroreceptor-HR reflex resetting. In addition, two
HR candidates were implicated in stress-dependent responses [47, 48]. First, studies in
CRHR2 knockout mice suggest its involvement in stress-responses in the brain and periph‐
ery [47]. Second, mice that overexpressed NPY showed enhanced sympatho-adrenal activity
and adaptive responses to various stresses [48]. Although gene targeting is widely used in
mice, transgenic rats can be generated by zinc-finger nucleases [49]. A recent report showed
successful generation of a renin knockout rat on the Dahl salt-sensitive background [50].
However, development of systems genetics approaches would dramatically elevate our un‐
derstanding of the contribution of the each regulatory component of HR variation. We think
that utilization of systems biology approaches will provide significantly more insights into
HR variation [51]. Ultimately, validation of the HR candidate genes and pathways in ani‐
mals will validate HR studies in humans. These research efforts may lead to personalized
diagnostic and treatment strategies for cardiovascular patients.
3. Conclusions
HR is regulated by very complex mechanisms (Fig. 1). Abnormal HR is a strong predictor
for cardiovascular diseases. However, pathophysiology of HR regulation is not well under‐
stood. It is also well established that genetic factors play an important role in HR variation.
Genetic studies in humans identified over 20 loci that are linked to the HR trait. Despite the
recent progress we can explain only a small portion of the genetic contribution to HR varia‐
tion. Inter-individual variability in hemodynamic parameters remains one of the key chal‐
lenges in large population studies. In fact, identification of the stress-related genes may
suggest that the methods of evaluation of HR might affect the stress-response in humans.
Genetic experiments in animals significantly reduce effects of the environmental/methodo‐
logical factors. However, only a similar number of the HR loci were identified in rodents
compared to humans (Tables 1-2). Overview of the candidates revealed that they contribute
to the HR variation via three major mechanisms: cardiomyocyte, neuronal cell functions and
stress-responses. In general, there is a lack of validation of both, human and animal studies.
We think that generation of transgenic animal models of HR candidate genes should also be
coupled with systems genetics approaches. Experimental studies will lead to translational
applications for preventing cardiovascular diseases related to HR pathophysiology.
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